Scott A. Kelly - 31 Mar 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CMO, Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol
CYDY
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 16:08:03 UTC
Previous filing
20 Oct 2021
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +15,592 +0.81% $0.000000 1,950,655 31 Mar 2022 Direct F1
transaction CYDY Common Stock Award $0 +21,367 +1.1% $0.000000 1,972,022 15 Apr 2022 Direct F1
transaction CYDY Common Stock Award $0 +18,029 +0.91% $0.000000 1,990,051 30 Apr 2022 Direct F1
transaction CYDY Common Stock Award $0 +16,968 +0.85% $0.000000 2,007,019 15 May 2022 Direct F1
transaction CYDY Common Stock Award $0 +18,029 +0.9% $0.000000 2,025,048 31 May 2022 Direct F1
holding CYDY Common Stock 782,408 31 Mar 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Remarks:

EX 24 - Power of Attorney